Ute Hoch
About Ute Hoch
Ute Hoch serves as the Vice President of Clinical Pharmacology and Quantitative Sciences at Nektar Therapeutics, a position she has held since 2020. She has extensive experience in the pharmaceutical industry, having previously worked as Executive Director of Clinical Pharmacology at Nektar and as a Senior Scientist at Sunesis Pharmaceuticals.
Current Role at Nektar Therapeutics
Ute Hoch serves as the Vice President of Clinical Pharmacology and Quantitative Sciences at Nektar Therapeutics. She has held this position since 2020, contributing to the company's focus on innovative drug development and clinical research. In this role, she oversees clinical pharmacology strategies and quantitative sciences, ensuring that the company's therapeutic candidates are developed effectively and efficiently.
Previous Experience at Nektar Therapeutics
Prior to her current role, Ute Hoch worked at Nektar Therapeutics as the Executive Director of Clinical Pharmacology from 2008 to 2020. During her 12 years in this position, she played a significant role in advancing the company's clinical programs and pharmacological strategies. Her tenure in San Francisco was marked by her involvement in various projects aimed at enhancing drug efficacy and safety.
Experience at Sunesis Pharmaceuticals
Before joining Nektar Therapeutics, Ute Hoch was employed at Sunesis Pharmaceuticals as a Senior Scientist from 2002 to 2008. In this role, she contributed to the development of novel therapeutics, focusing on clinical pharmacology and drug development processes. Her six years at Sunesis Pharmaceuticals provided her with valuable experience in the pharmaceutical industry.
Education and Expertise
Ute Hoch earned her Ph.D. in Food Chemistry from The Julius Maximilians University of Würzburg. Her academic journey spanned 18 years, from 1988 to 2006, during which she developed a strong foundation in scientific research and methodologies. This educational background supports her expertise in clinical pharmacology and quantitative sciences.